← Back to Search

Behavioural Intervention

high-dose moderate to vigorous physical activity (MVPA) for Depression

N/A
Recruiting
Led By A'Naja Newsome, PhD
Research Sponsored by University of Central Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Enrolled UCF college students aged 18 to 25
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial aims to study the effects of exercise on depression, BDNF, enjoyment, affect, and quality of life in college students.

Who is the study for?
This trial is for UCF college students aged 18 to 25 with mild to moderate depression who are willing and physically able to exercise. Participants must be okay with wearing a Fitbit and not underweight, pregnant, nursing, or smokers. They can't join if they have certain mental health conditions, take beta-blockers, or have been advised against giving blood.Check my eligibility
What is being tested?
The study examines how different amounts of exercise affect depression symptoms in sedentary young adults. It also looks at changes in BDNF levels after exercising for ten weeks and assesses the impact on enjoyment and quality of life.See study design
What are the potential side effects?
Since this trial involves physical activity as an intervention rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue but will vary based on individual fitness levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a UCF student aged 18 to 25.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain-derived Neurotrophic Factor (BDNF) assay
Secondary outcome measures
Fitbit for heart rate
Fitbit for physical activity data

Trial Design

3Treatment groups
Experimental Treatment
Group I: walking attention controlExperimental Treatment1 Intervention
Participants will be provided sleep education material and will be asked to perform 15 minutes of leisure walking three times per week. This exercise intensity does not meet the recommended volume of exercise necessary for health benefits. Instructing participants to walk will reduce the likelihood that participants will undertake a more vigorous exercise routine. Participants will be asked to track their sleep each night using Fitbit.
Group II: moderate-dose moderate to vigorous physical activity (MVPA)Experimental Treatment1 Intervention
Participants will be asked to perform a moderate-dose (MD) (i.e., 150 minutes of moderate to vigorous physical activity (MVPA) per week) of structured exercise for 10 weeks. Exercise modality and schedule will be participant- selected and may consist of any combination of aerobic and strength training that elevates the heart rate between 64 - 95 percent of estimated heart rate max. Participants will be asked to track their activity using Fitbit.
Group III: high-dose moderate to vigorous physical activity (MVPA)Experimental Treatment1 Intervention
Participants will be asked to perform a high-dose (HD) (i.e., 300 minutes of moderate to vigorous physical activity (MVPA) per week) of structured exercise for 10 weeks. Exercise modality and schedule will be participant- selected and may consist of any combination of aerobic and strength training that elevates the heart rate between 64 - 95 percent of estimated heart rate max. Participants will be asked to track their activity using Fitbit.

Find a Location

Who is running the clinical trial?

American College of Sports MedicineOTHER
11 Previous Clinical Trials
301 Total Patients Enrolled
University of Central FloridaLead Sponsor
79 Previous Clinical Trials
1,098,312 Total Patients Enrolled
A'Naja Newsome, PhDPrincipal InvestigatorUniversity of Central Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on participants in this medical research?

"Affirmative, according to the clinicaltrials.gov website this study is currently soliciting for participants. Initially posted on July 1st 2023, and recently updated on December 8th 2023, 48 individuals need to be recruited at one site in order for the trial to reach completion."

Answered by AI

Who would meet the criteria for enrollment in this experiment?

"This clinical trial, which is seeking 48 participants, requires that prospective patients have a diagnosis of depression and be between 18 to 25 years old."

Answered by AI

Is this experimentation actively enrolling participants?

"Affirmative, according to the clinicaltrials.gov portal this medical trial is actively seeking participants. It was initially posted on July 1st 2023 and last updated on December 8th 2023. The research team requires 48 patients from a single site for enrolment."

Answered by AI

Does this research endeavor accommodate individuals below the age of 55?

"This research requires participants aged 18 to 25. In contrast, there are 225 clinical trials specifically for individuals under the age of 18 and 1020 studies accommodating persons over 65 years old."

Answered by AI

Who else is applying?

What site did they apply to?
University of Central Florida
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

To try to find a solution and answer to my deep depression.
PatientReceived no prior treatments
~27 spots leftby Apr 2025